What are the prospects for the future development of pharmacies and the prospects for opening pharma

The chain rate is constantly increasing

In 2010, the proportion of the number of chain pharmacies in China was only, and in 2019, it increased year by year, and there are two reasons for the increase year by year. Volume-based procurement.

Under the influence of other policies, the bargaining power of small and medium-sized pharmacies is weak, and the growth rate of the same store is even negative. The second is that chain retail enterprises generally have strong capital strength and refined management.

and strong bargaining power for competitive advantage in licensed pharmacists.

In terms of capital, manufacturer resources, and first-class chain capabilities, it is ahead of other small and medium-sized pharmacies.

Development trend 1: The speed of mergers and acquisitions is accelerating

The rising cost of expansion has promoted the concentration of advantages of leading enterprises, and the development ceiling of small and medium-sized chain and single pharmacies.

Obviously, the industry will usher in a rapid increase in concentration, from the listed retail pharmacies as a whole to maintain a growth of more than 20%, the increase in concentration is the core factor for the growth of the retail pharmacy industry. Compared with the United States and Japan, the concentration of China's pharmaceutical retail industry.

Lower, 2019 US top

3. The number of pharmacies owned by chain pharmacies exceeds 30%, contributing more than 80% of sales, and the sales of Japan's top 10 chain pharmacies account for the industry market share.

On the other hand, China's top in 2019

The number of 10 chain pharmacies only accounts for the total number of pharmacies, and the proportion of sales is only 22%, so there is still huge room for improvement in the concentration of China's pharmaceutical retail industry. With the increasing standardization of the management of taxation and the Food and Drug Administration, the increase of industry concentration, and the integration of small and medium-sized chain pharmacies by the chain head enterprises with standardized operation, the pharmaceutical retail industry will operate more standardly, and promote the healthy development of the industry.

Development trend 2: Accelerate the online layout

According to data from Minenet, the sales scale of China's physical pharmacies and online pharmacies (including drugs + non-drugs) reached 662 billion yuan in 2019, of which the sales scale of physical pharmacies accounted for a year-on-year decline, with a growth rate of ; Online pharmacies are developing rapidly, with the proportion of their sales increasing from 2013 to 2019, with a compound annual growth rate from 2013 to 2019.

and are growing at an annual rate of more than 95%. It can be seen that the e-commerce business.

It has already had a certain impact on offline store sales, and in the future, with the advancement of regulatory policies, technological progress, and further changes in consumer consumption habits, small and medium-sized pharmacies that have not yet deployed pharmaceutical e-commerce will be more impacted.

B2C third-party platforms are still the main channels for pharmaceutical e-commerce, including Tmall Pharmacy, Jingdong Pharmacy, and Pinduoduo.

Pharmacy Network** and other platforms, 4 platforms have online pharmacies as of 2020; The product categories of the B2C platform are mainly drugs, among which, the proportion of drugs in Tmall Pharmacy is JD.com**.

Proportion of drugs. Under the situation of declining > and decreasing customer flow, retail pharmacies should actively deploy online business, explore more business opportunities in four major scenarios such as medical consultation, remote diagnosis and treatment, drug purchase, and health management, broaden business areas, and use online traffic to guide offline traffic, and finally form an online + offline closed-loop development.

Major listed companies in the pharmaceutical retail industry:At present, the relevant listed companies in the domestic pharmaceutical retail industry include Sinopharm Holdings (Dashenlin) (Yifeng Pharmacy (Laomin (Yixintang (Tongrentang (Shuyu) Civilian (Jianzhijia (etc.).

China's pharmaceutical retail sales revenue data, China's pharmacy scale data, etc.

The market size is growing steadily

In recent years, with the further improvement of industry concentration and drug retail chain operation rate, the problems of small and scattered drug retail enterprises in China have been significantly improved. Since 2015, with the deepening of the reform of China's pharmaceutical retail industry, the growth momentum of the number and scale of China's pharmacy retail enterprises has slowed down, and by the end of 2020, the number of pharmacy retail enterprises in the country has declined to 6,298, a decrease of nearly 400 from the same period last year.

From 2014 to 2020, the growth rate of China's drug retail market remained between 9% and 10%, and by 2020, the national drug retail market size increased to 511.9 billion yuan.

Pharmacy chains became mainstream

As a major player in drug retail, the number of pharmacies in China has maintained a continuous growth trend since 2012, and data shows that by the end of 2019, the number of pharmacies in China exceeded 500,000 for the first time. In 2020, the number of pharmacies nationwide will further increase to 10,000.

From the perspective of the structure of pharmacies, with the continuous advancement of the reform of China's drug retail market, the development trend of chain pharmacies gradually replacing single pharmacies has taken shape. In 2012, there were only 10,000 chain pharmacies in China, accounting for the total number of pharmacies, while there were 10,000 single pharmacies, accounting for the total number of pharmacies. Since 2017, when the scale of chain pharmacies in China exceeded that of single pharmacies for the first time, the market share of chain pharmacies has continued to increase.

By the end of 2020, the total number of chain pharmacies in China is 10,000, accounting for the total number of pharmacies, while there are 10,000 single pharmacies, accounting for the total number of pharmacies. Judging from the current development trend of the industry, the market share of single pharmacies will be further squeezed by chain pharmacies in the future.

NUS Pharmacy is firmly at the top of the list

In terms of enterprises, chain pharmacy enterprises have obvious advantages in China's drug retail market by virtue of their large-scale development strategy, and Guoda Pharmacy, a subsidiary of China Pharmaceutical Group, is the leader. In 2020, Guoda Pharmacy ranked first in the pharmaceutical retail industry with drug sales of 100 million yuan; Dashenlin, Laobaimin, Yifeng Pharmacy, Yixintang, etc. followed, with sales of more than 10 billion yuan.

"Pharmaceutical Market Development Prospect Research Report" is a report on the development of the pharmaceutical industry in the domestic market, which began in 2010 and ended in 2011.

What is the future direction of pharmacy?

Nowadays, in the face of increased homogeneous competition and diversified user needs, many offline chain pharmacies have no choice but to take the digital transformation and upgrading of their business as the key to achieving a breakthrough in their operations. Relying on the current advanced Internet technology resources and the pharmaceutical chain system, many pharmaceutical companies have developed online platforms such as apps and small programs, and then invited their chain stores to settle in, so as to help traditional pharmacies transform and upgrade and comprehensively improve the comprehensive service capabilities of pharmacies.

The pharmaceutical platform on the market provides a variety of services, including remote consultation, drug purchase, home delivery and other one-stop services, users can even enjoy the group to buy drugs, membership points, apply to be its distributor and other functions, which is the flexible and convenient operation brought by the smart terminal.

However, in the development process of the pharmaceutical business, there is a problem that the platform urgently needs to solve, how can the platform realize the function of master accounting? It is necessary to solve the payment problem of users, make online transactions more efficient, and the platform side needs to unify the collection and payment of a large number of first-class merchants and chain pharmacies, etc., and it is necessary to improve the situation of complex accounting processing and low human efficiency. The payment sub-account system naturally has the function of sub-accounting, and provides a package of comprehensive solutions such as fund bookkeeping, sub-accounting, reconciliation and clearing for the core problems of transaction settlement of platform enterprises, as well as multi-channel payment application solutions in multi-business scenarios, with the help of which the above business pain points can be successfully solved.

In terms of payment, the system supports many mainstream payment channels, which can provide a high-quality payment experience for the pharmaceutical platform, eliminating the complex access process, and can be easily accessed with only one interface, so that C-end users can directly operate on the platform and enjoy various services provided by the platform, and increase user stickiness by improving the payment experience; In terms of account sharing, the system can realize automatic account sharing by configuring account sharing rules in the background, effectively improving the efficiency of user fund management and the settlement efficiency of stores and distributors. In terms of compliance, the system is based on the closed management of bank accounts, which can quickly avoid the risk of "two clearances" of the platform and ensure the compliance of the business.

With the gradual advancement of medical reform, the first consultation and online drug sales have been continuously liberalized, while traditional offline chain pharmacies can only provide a single drug service, which is difficult to meet the diverse needs of consumers. In the future, more and more pharmaceutical companies will continue to make efforts in industrial innovation, use advanced technologies such as the Internet, big data, and artificial intelligence to empower pharmacies, and help more pharmacies achieve digital upgrades in actual scenarios.

If you're in a good location, you can still give it a try.

The reason why pharmacies make money (1) do not bargain: unless there are several commonly used drugs, everyone has a little knowledge of **, and the rest of the drug prices are not clear to the general public, and many people rarely shop around for drugs, and pharmacies are not two prices, how much is how much (2) not only selling: I still remember when we bought drugs when we were children, pharmacies were after opening the box and picking up the medicine according to the amount.

3) Medical insurance card arbitrage: the funds of the medical insurance card can not be withdrawn, but also give the pharmacy arbitrage space, other places I don't know, our pharmacies here many also sell daily necessities (such as dish soap, toothpaste, shampoo, etc.), ** more expensive than the supermarket about 10%-20%, which gives many users who want to cash out the funds in the medical insurance card a chance to realize, with the medical insurance card to buy daily necessities, the system is a drug. (4) Health care products:

Health care products should also be another high point for pharmacies' profits.

Summary. Dear dear, pharmacies have a very important position as retail stores that provide pharmaceutical products and services. With an aging population and increasing demand for health and medical services, the outlook for the future of pharmacies is relatively positive.

Dear Hello, pharmacies, as retail stores that provide Yiliang products and services, have a very important position. With an ageing population and increasing demand for health and medical services, the outlook for pharmacies is relatively positive.

How to choose a location. Hello dear, here are some of the trends that could have a positive impact on the future of pharmacies:1 Increased health awareness:

Increased health awareness means that they are more willing to focus on ways to prevent disease and stay healthy, which will lead to more people seeking help from pharmacies. 2. Aging population: With the aging of the population, the population that needs long-term medication and ** increases, which will also provide more opportunities for pharmacies.

3. Application of new technologies: Pharmacies can also use new technologies to improve service quality and efficiency. For example, through electronic prescriptions, vending machines, etc., customer experience can be improved and efficiency can be improved.

Can an exclusive community pharmacy do it.

Hello dear, you can do it in a place with a lot of residents.

Will you lose money by opening a pharmacy.

Hello dear, you will not lose money by opening a pharmacy.

How to tell. Hello.

In the current chain pharmacy, the gross profit margin that is doing well is about 40%, but its own cost will reach 38%, which means that your net profit is about 2 points, plus the cost of the reputation of the backstage, it is estimated that it will be 3. Individual pharmacies are relatively low-cost, with a net profit margin of about 8 to 10 points. With the development of pharmacies to this day, the market competition has been relatively fierce, taking Guangzhou as an example, there are more pharmacies than rice stores and bank stores.

Profit margins have met the requirements of the market, any industry, as long as there is full market competition, its profits will gradually decline, and finally return to a reasonable space.

Hello, the prospects for pharmacies are very promising! With the development of the global economy and the improvement of people's living standards, the pharmaceutical industry has gradually developed and expanded, and pharmacies have also benefited. In the future, due to the research and development and application of more and more new drugs, as well as people's higher and higher requirements for drug quality, its market prospects are very broad.

In addition, in recent years, many countries have supported the development of pharmacies in all aspects, and a series of policies and measures such as franchise, expansion and information construction of pharmacies have made pharmacies have greater advantages in financial support and management, thus making better contributions to the development of pharmacies. In addition, the application of new health services and solutions will also bring more possibilities for the development of pharmacies. With the continuous development of science and technology, such as health management, drug management, drug analysis, etc., more opportunities will be created for enterprises that provide pharmacy services.

In short, the future of pharmacies is bright, and its development is very fast, and it is expected to become the mainstream development of China's pharmaceutical industry. The hood is good.

Hello dear, glad to answer for you. The development prospects of the pharmaceutical industry are very good. In recent years, with the increase of per capita income level and the increasing aging of the population, China's pharmaceutical consumption expenditure has continued to grow, and the scale has been expanding, and it has become the world's largest emerging pharmaceutical market.

Driven by the diversification of pharmaceuticals and the growing demand for drugs, China's pharmaceutical market is showing a steady upward trend. According to relevant data, the size of China's pharmaceutical market in 2021 will reach 1,853.9 billion yuan. It is estimated that the market size of China's pharmaceutical industry will continue to expand in 2022, reaching 1,853.9 billion yuan.